This article is more than 5 years old. Information may no longer be current.
I-Optics nonmydriatic retinal imaging system receives FDA approval
Click Here to Manage Email Alerts
NEW YORK — I-Optics announced here at Vision Expo East that its EasyScan zero-dilation retinal imaging system has received U.S. Food and Drug Administration approval.
The device provides a fast and easy workflow with automated functions and intuitive controls that reduce examination times and create a positive patient experience, according to company literature. Specific features include a confocal scanning laser ophthalmoscope optical engine; capture modes of green (532 nm), near infrared (785 nm) and combined pseudo color; a field angle of 45°; alignment help; fixation targets; autofocus and autocapture capabilities; auto-exposure flash settings; an emmetropia compensation of +/- 10 D; networking capabilities; multiple image formats (.tiff, .tif, .jpeg and .bmp); and a compact, portable design that is powered by USB and weighs less than 7 kg.
According to i-Optics' sales manager, Wayne Kuykendall, the first system was delivered to eye care practices in December 2011.